City of Hope, a NCI-designated Comprehensive Cancer Center
Skip Navigation
City of Hope has long been a leader in lymphoma research. With our extensive program of clinical trials investigating promising new treatments, we can provide our patients access to novel therapies that are not yet available elsewhere for the treatment of lymphoma. Our Developmental Therapeutics Program has a very active portfolio of trials for patients with recurrent lymphoma.
To learn more about our clinical trials program and specifically about trials for lymphoma, click here
With your help, City of Hope researchers pursue new clinical and laboratory findings, support promising young scientists, and acquire new laboratory technology.
Contact Donor Relations at 800-720-6824 for more information.
With your help, City of Hope researchers pursue new clinical and laboratory findings, support promising young scientists, and acquire new laboratory technology.